Literature DB >> 18432888

Measurement of interleukin-13.

Angus Lauder1, Andrew N J McKenzie.   

Abstract

This unit describes two protocols that can be used to quantitate interleukin-13 (IL-13). The enzyme-linked immunosorbent assay (ELISA) has the advantage of being highly specific for human IL-13 and does not recognize other cytokines present in the sample. A bioassay is also presented based on the ability of IL-13 to stimulate the growth of the B9 plasmacytoma cell line. The bioassay method can be used to detect both mouse and human IL-13. B9 cells are dependent on IL-6 for growth and will also respond to IL-4. Thus, although B9 cells can readily be used to quantify IL-13 in the absence of other cytokines, neutralizing antibodies must be incorporated into the bioassay when other cytokines are present in the sample.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 18432888     DOI: 10.1002/0471142735.im0618s46

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  1 in total

1.  Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma.

Authors:  Sanchaita Sriwal Sonar; Yen-Ming Hsu; Melanie Lynn Conrad; Gerard R Majeau; Ayse Kilic; Ellen Garber; Yan Gao; Chioma Nwankwo; Gundi Willer; Jan C Dudda; Hellen Kim; Véronique Bailly; Axel Pagenstecher; Paul D Rennert; Harald Renz
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.